papaverine has been researched along with Autoimmune Diabetes in 5 studies
Papaverine: An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.
papaverine : A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Only one patient had non-organic impotence." | 2.67 | Impotence in diabetes: aetiology, implications for treatment and preferred vacuum device. ( Close, CF; Hardisty, CA; Moore, KT; Moriarty, KT; Ryder, RE, 1992) |
| "Treatment with papaverine injections is generally inexpensive and effective to overcome the multifactorial causes of erectile dysfunction in this population." | 1.29 | Aetiopathogenesis and management of impotence in diabetic males: four years experience from a combined clinic. ( Boulton, AJ; Chen, TF; Payne, S; Veves, A; Webster, L, 1995) |
| "papaverine was not significantly different in patients operated in low epidural and general anaesthesia (n = 8)." | 1.29 | Intra-arterial papaverine and leg vascular resistance during in situ bypass surgery with high or low epidural anaesthesia. ( Jensen, LP; Lorentzen, JE; Rørdam, P; Schroeder, T; Secher, NH, 1993) |
| "The treatment of impotence in diabetic men with vacuum tumescence therapy was studied in a specialist clinic." | 1.28 | The management of impotence in diabetic men by vacuum tumescence therapy. ( Bentley, S; Cooksey, G; Hearnshaw, JR; Jehu, D; Osborn, DE; Price, DE, 1991) |
| "Diabetic microangiopathy is regarded as the most important pathogenic factor." | 1.27 | [Disorders of erectile potency in diabetes mellitus]. ( Floth, A; Holzmann, RM; Schramek, P, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Veves, A | 1 |
| Webster, L | 1 |
| Chen, TF | 1 |
| Payne, S | 1 |
| Boulton, AJ | 1 |
| Rørdam, P | 1 |
| Jensen, LP | 1 |
| Schroeder, T | 1 |
| Lorentzen, JE | 1 |
| Secher, NH | 1 |
| Ryder, RE | 1 |
| Close, CF | 1 |
| Moriarty, KT | 1 |
| Moore, KT | 1 |
| Hardisty, CA | 1 |
| Price, DE | 1 |
| Cooksey, G | 1 |
| Jehu, D | 1 |
| Bentley, S | 1 |
| Hearnshaw, JR | 1 |
| Osborn, DE | 1 |
| Schramek, P | 1 |
| Holzmann, RM | 1 |
| Floth, A | 1 |
1 trial available for papaverine and Autoimmune Diabetes
| Article | Year |
|---|---|
Impotence in diabetes: aetiology, implications for treatment and preferred vacuum device.
Topics: Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Erec | 1992 |
4 other studies available for papaverine and Autoimmune Diabetes
| Article | Year |
|---|---|
Aetiopathogenesis and management of impotence in diabetic males: four years experience from a combined clinic.
Topics: Adult; Aged; Algorithms; Counseling; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus | 1995 |
Intra-arterial papaverine and leg vascular resistance during in situ bypass surgery with high or low epidural anaesthesia.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Epidural; Arterial Occlusive Diseases; Diabetes Mellitus | 1993 |
The management of impotence in diabetic men by vacuum tumescence therapy.
Topics: Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Erectile Dysfunction; Human | 1991 |
[Disorders of erectile potency in diabetes mellitus].
Topics: Aged; Alprostadil; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diab | 1988 |